PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsLice infestations
MeSH D010373 - lice infestations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012876:Parasitic skin diseases
0 Companies
0 Drugs
Success rate
D004478:Ectoparasitic infestations
0 Companies
0 Drugs
Success rate
D010373: 
Lice infestations
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIvermectin Ivermectin  2019-09-13   
PadagisIvermectin Ivermectin  2020-04-13   
Permethrin Permethrin  2003-04-21   
Taro PharmaceuticalIvermectin Ivermectin  2020-05-06   
Malathion Ovide 2026-08-14 1982-08-02   
MylanMalathion Malathion  2009-03-06   
PerrigoPermethrin Permethrin  2001-12-20   
GSKPermethrin Nix  1986-03-31   
Merck & CoIvermectin Stromectol  1996-11-22   
BayerPiperonyl butoxide, Pyrethrins Rid Mousse  2000-03-07   
Aurobindo PharmaPermethrin Elimite  1989-08-25   
Zydus TherapeuticsIvermectin Ivermectin  2022-08-02   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
33%
2/6
Phase 2
50%
1/2
Phase 3
100%
11/11
Approved: 7Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use